masld glp 1 Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists Direct and indirect effects of
Description
Contact Information Company: Trimology Weight Return Address: Returns66, 11870 62nd St

Many patients find that dietary changes and time eliminate the need for daily acid-suppressing medication

RAAS inhibitors remain foundational, especially for albuminuric CKD, while GLP-1RAs offer modest albuminuria reduction and strong cardiovascular benefit, but less direct renal protection compared to SGLT2is [123]

This is especially relevant for people who are on GLP-1 medications and want to support their results, or who have stopped them and are trying to maintain outcomes
and marketing that obscures which entity actually compounds the medication

Diets alone often failed
